Article Details

Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse

Retrieved on: 2021-02-04 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse. View article details on hiswai:

Excerpt

Pfizer's interest in the platform is underpinned by evidence that it can generate therapies that treat autoimmune diseases without affecting the normal ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up